tiprankstipranks
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market
Holding VVOS?
Track your performance easily

Vivos Therapeutics (VVOS) Income Statement

193 Followers

Vivos Therapeutics Income Statement

Last quarter (Q3 2024), Vivos Therapeutics's total revenue was $3.86M, an increase of 13.70% from the same quarter last year. In Q3, Vivos Therapeutics's net income was $-2.62M. See Vivos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 14.63M$ 13.80M$ 16.02M$ 16.89M$ 13.07M$ 11.39M
Cost of Revenue
$ 5.81M$ 5.53M$ 6.00M$ 4.28M$ 2.65M$ 2.74M
Gross Profit
$ 8.82M$ 8.27M$ 10.02M$ 12.60M$ 10.41M$ 8.66M
Operating Expense
$ 9.23M$ 25.57M$ 35.05M$ 32.99M$ 22.45M$ 19.23M
Operating Income
$ -11.86M$ -17.30M$ -25.03M$ -20.38M$ -12.04M$ -10.58M
Net Non Operating Interest Income Expense
$ ―$ ―$ 89.00K$ -14.00K$ -96.00K$ -116.74K
Other Income Expense
$ -1.60M$ -10.17M$ -1.10M$ 9.00K$ -3.60M$ -60.34K
Pretax Income
$ -10.40M$ -13.58M$ -23.84M$ -20.29M$ -12.06M$ -10.75M
Tax Provision
$ ―$ -365.00K$ 510.00K$ -502.00K$ -181.00K$ 0.00
Earnings From Equity Interest Net Of Tax
$ ―$ ―$ 1.29M$ ―$ ―$ ―
Net Income Common Stockholders
$ -10.40M$ -13.58M$ -23.84M$ -20.29M$ -17.99M$ -11.75M
Basic EPS
$ -4.38$ -11.14$ -1.04$ -24.00$ -35.00$ -0.67
Diluted EPS
$ -4.38$ -11.14$ -1.04$ -24.00$ -35.00$ -0.67
Basic Average Shares
$ 13.35M$ 1.22M$ 23.01B$ 849.32K$ 514.77K$ 17.67M
Diluted Average Shares
$ 13.35M$ 1.22M$ 23.01B$ 849.32K$ 514.77K$ 17.67M
Dividend Per Share
$ ―$ ―$ ―$ ―$ ―$ ―
Total Operating Income As Reported
$ ―$ ―$ ―$ ―$ ―$ ―
Reported Normalized Basic E P S
$ ―$ ―$ ―$ ―$ ―$ ―
Reported Normalized Diluted E P S
$ ―$ ―$ ―$ ―$ ―$ ―
Rent Expense Supplemental
$ ―$ ―$ ―$ ―$ ―$ ―
Total Expenses
$ 12.23M$ 31.10M$ 41.05M$ 37.27M$ 25.11M$ 21.97M
Net Income From Continuing And Discontinued Operation
$ -10.40M$ -13.58M$ -23.84M$ -20.29M$ -12.06M$ -10.75M
Normalized Income
$ -6.15M$ ―$ ―$ ―$ ―$ -10.69M
Interest Expense
$ ―$ ―$ ―$ ―$ ―$ 137.88K
EBIT
$ -11.82M$ -7.50M$ -23.84M$ -20.27M$ -11.96M$ -10.62M
EBITDA
$ -11.23M$ -6.87M$ -23.18M$ -19.54M$ -11.24M$ -9.87M
Currency in USD

Vivos Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis